|
|
|
Insider
Information: |
Carter Bruce L A |
Relationship: |
|
City: |
Seattle |
State: |
WA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
183,977 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,160,481 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
183,977 |
|
|
Total
Value |
$1,160,481 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
56.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Zymogenetics Inc |
ZGEN |
Director |
2010-10-08 |
115,399 |
2004-06-21 |
0 |
Premium* |
|
Novelion Therapeutics Inc |
NVLN |
Director |
2009-05-14 |
20,000 |
2009-05-14 |
0 |
Premium* |
|
Regulus Therapeutics Inc. |
RGLS |
Director |
2015-04-13 |
0 |
2015-04-13 |
0 |
Premium* |
|
Xencor Inc |
XNCR |
Director |
2017-06-14 |
48,578 |
2015-06-15 |
0 |
Premium* |
|
Enanta Pharmaceuticals Inc |
ENTA |
Director |
2022-03-21 |
0 |
2019-02-11 |
0 |
Premium* |
|
Mirati Therapeutics, Inc. |
MRTX |
|
2024-01-23 |
0 |
2019-02-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
61 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ZGEN |
Zymogenetics Inc |
CEO & Chairman of the Board |
|
2008-02-19 |
4 |
B |
$9.13 |
$100,462 |
D/D |
11,000 |
158,149 |
2.81 |
- |
|
NVLN |
Novelion Therapeutics Inc |
Director |
|
2009-05-14 |
4 |
B |
$2.07 |
$41,400 |
D/D |
20,000 |
20,000 |
2.39 |
- |
|
ZGEN |
Zymogenetics Inc |
Director |
|
2010-08-19 |
4 |
OE |
$2.78 |
$1,183,300 |
D/D |
426,000 |
584,149 |
0 |
- |
|
ZGEN |
Zymogenetics Inc |
Director |
|
2010-10-08 |
4 |
D |
$9.75 |
$4,570,313 |
D/D |
(468,750) |
115,399 |
0 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
Director |
|
2015-04-13 |
4 |
S |
$17.66 |
$353,164 |
D/D |
(20,000) |
0 |
0 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
Director |
|
2015-04-13 |
4 |
OE |
$4.78 |
$95,600 |
D/D |
20,000 |
20,000 |
0 |
- |
|
XNCR |
Xencor Inc |
Director |
|
2015-06-15 |
4 |
S |
$19.21 |
$192,114 |
D/D |
(10,000) |
0 |
0 |
- |
|
XNCR |
Xencor Inc |
Director |
|
2015-06-15 |
4 |
OE |
$0.59 |
$5,900 |
D/D |
10,000 |
10,000 |
0 |
- |
|
XNCR |
Xencor Inc |
Director |
|
2016-08-11 |
4 |
OE |
$0.59 |
$5,900 |
D/D |
10,000 |
10,000 |
0 |
- |
|
XNCR |
Xencor Inc |
Director |
|
2016-08-15 |
4 |
S |
$22.67 |
$77,074 |
D/D |
(3,400) |
6,600 |
0 |
- |
|
XNCR |
Xencor Inc |
Director |
|
2017-05-24 |
4 |
OE |
$0.59 |
$45,279 |
D/D |
76,744 |
83,344 |
0 |
- |
|
XNCR |
Xencor Inc |
Director |
|
2017-05-26 |
4 |
S |
$22.04 |
$275,213 |
D/D |
(12,400) |
70,944 |
0 |
- |
|
XNCR |
Xencor Inc |
Director |
|
2017-06-02 |
4 |
S |
$22.00 |
$52,052 |
D/D |
(2,366) |
68,578 |
0 |
- |
|
XNCR |
Xencor Inc |
Director |
|
2017-06-14 |
4 |
S |
$20.61 |
$412,238 |
D/D |
(20,000) |
48,578 |
0 |
- |
|
ENTA |
Enanta Pharmaceuticals In... |
Director |
|
2019-02-11 |
4 |
AS |
$90.02 |
$246,102 |
D/D |
(2,734) |
0 |
0 |
- |
|
ENTA |
Enanta Pharmaceuticals In... |
Director |
|
2019-02-11 |
4 |
OE |
$23.40 |
$63,976 |
D/D |
2,734 |
2,734 |
0 |
- |
|
ENTA |
Enanta Pharmaceuticals In... |
Director |
|
2019-02-12 |
4 |
AS |
$90.00 |
$450,000 |
D/D |
(5,000) |
0 |
0 |
- |
|
ENTA |
Enanta Pharmaceuticals In... |
Director |
|
2019-02-12 |
4 |
OE |
$23.40 |
$117,000 |
D/D |
5,000 |
5,000 |
0 |
- |
|
ENTA |
Enanta Pharmaceuticals In... |
Director |
|
2019-03-11 |
4 |
AS |
$99.16 |
$153,301 |
D/D |
(1,546) |
0 |
0 |
- |
|
ENTA |
Enanta Pharmaceuticals In... |
Director |
|
2019-03-11 |
4 |
OE |
$23.40 |
$36,176 |
D/D |
1,546 |
1,546 |
0 |
- |
|
ENTA |
Enanta Pharmaceuticals In... |
Director |
|
2022-03-21 |
4 |
OE |
$25.58 |
$153,480 |
D/D |
6,000 |
6,000 |
0 |
- |
|
ENTA |
Enanta Pharmaceuticals In... |
Director |
|
2022-03-21 |
4 |
AS |
$66.70 |
$406,970 |
D/D |
(6,000) |
0 |
0 |
% |
|
MRTX |
Mirati Therapeutics, Inc. |
Director |
|
2023-12-29 |
4 |
A |
$58.75 |
$399,970 |
D/D |
6,808 |
17,273 |
0 |
- |
|
ZGEN |
Zymogenetics Inc |
officerTitle |
|
2006-01-09 |
4 |
OE |
$2.78 |
$69,500 |
D/D |
25,000 |
156,299 |
|
- |
|
ZGEN |
Zymogenetics Inc |
officerTitle |
|
2006-01-09 |
4 |
AS |
$19.92 |
$498,000 |
D/D |
(25,000) |
131,299 |
|
- |
|
61 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|